The manufacturer of a new drug claims that it will lower
blood pressure by 13 points on the average. When the drug was
administered to 6 patients, the following drops in blood pressure
were registered: 12, 8, 15, 9, 10 and 16. Is the claim sustained at
the 0.05 level of significance.
Mean =
Variance of population
The following null and alternative hypotheses need to be tested:
This corresponds to a two-tailed test, for which a t-test for one mean, with unknown population standard deviation, using the sample standard deviation, will be used.
Based on the information provided, the significance level is degrees of freedom, and the critical value for a two-tailed test is The rejection region for this two-tailed test is
The t-statistic is computed as follows:
Since it is observed that it is then concluded that the null hypothesis is not rejected.
Using the P-value approach:
The p-value for two-tailed degrees of freedom, is and since it is concluded that the null hypothesis is not rejected.
Therefore, there is not enough evidence to claim that the population mean is different than 13, at the significance level.
Comments